ROR1 and neuroendocrine neoplasm: ROR1 expression was significantly higher in non-squamous (136/157, 86%) and squamous (60/106, 57%) lung cancer patients compared to 5/24 (21%) patients with neuroendocrine tumors (p = 0.0001) (Table S1).